Suzetrigine Frame Trial Comparing Suzetrigine and Acetaminophen
Part of paid clinical trials in Winston-Salem, North Carolina.
- Sponsor
- Wake Forest University Health Sciences
- Study ID
- NCT07525219
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Analgesic Efficacy
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Suzetrigine — DRUG100mg - Medication is self-administered at home on an empty stomach approximately 1-6 hours prior to the procedure.
- acetaminophen — DRUG1000mg - Medication is self-administered at home on an empty stomach approximately 1-6 hours prior to the procedure.
Study Details
Local anesthetic infiltration is a primary source of acute pain during stereotactic procedures.
Key Dates
- First listed
- Apr 13, 2026
- Start date
- Jun 22, 2026
- Status verified
- Apr 2026
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: Acetaminophenacetaminophen (1000 mg) - is self-administered at home on an empty stomach approximately 1-6 hours prior to the procedure.
- Experimental: SuzetrigineSuzetrigine (100mg) - is self-administered at home on an empty stomach approximately 1-6 hours prior to the procedure.
Primary Outcome Measure
Visual Analog Scale (VAS-Anxiety) score [ Time Frame: Baseline ]
Central Contacts
- Wendy Jenkins, BSN RN, CCRC336.716.3842
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 |
Find similar trials in Winston-Salem, NC
By research site